Top Markets
#1 Venom Venom +71.25%
#2 Celer Network Celer Network +24.95%
#3 Akedo Akedo +23.31%
#4 Zilliqa Zilliqa +15.03%
#5 Backpack Backpack +13.60%
#6 Threshold Network Threshold Network +13.34%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.28%
#8 Ontology Gas Ontology Gas +11.06%
#9 ZKsync ZKsync +8.25%
#10 Ore Ore +7.94%
Coin of the day
Venom Venom
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Medtronic plc Medtronic plc

Medtronic plc

MDT
Classement en actions #189
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Prix de l'action
$92.21
Dernière synchronisation: 2026-09-18
Capitalisation boursière
$118.03B
Changement (1 jour)
-0.78%
Changement (1 an)
-3.43%
Pays
IE
Échange Medtronic plc (MDT)

Catégorie

Healthcare
Ratio P/E pour Medtronic plc (MDT)
Ratio P/E au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Medtronic plc, le ratio P/E actuel (TTM) est de 0. À la fin de l’année 2026, le P/E de l’entreprise était de 0.
Historique du ratio P/E pour Medtronic plc de 2026 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
Pas assez de données pour les dates fournies.
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 33.15 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 28.97 -
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 18.17 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 49.15 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.